Buscar
Mostrando ítems 1-10 de 96
Gastric Damage and Cancer-Associated Biomarkers in Helicobacter pylori-Infected Children
(Frontiers Media, 2020)
Helicobacter pylori (H. pylori) is well-known to be involved in gastric carcinogenesis, associated with deregulation of cell proliferation and epigenetic changes in cancer-related genes. H. pylori infection is largely ...
Clinico-pathological investigation on patients with "early gastric cancer" and "intermediate gastric cancer" in Chile
(1976)
We reported the final results obtained in a group of 30 patients with gastric cancer confined to the mucosa or submucosa (early gastric cancer) and in 29 cases with cancer infiltration up to the muscularis propria (intermediate ...
Helicobacter pylori and epigenetic mechanisms underlying gastric carcinogenesis
(Baishideng Publishing Group Inc., 2015)
The sequence of events associated with the development of gastric cancer has been described as "the gastric precancerous cascade". This cascade is a dynamic process that includes lesions, such as atrophic gastritis, ...
Gastric cancer: Overview
(2013-11-22)
Gastric cancer ranks fourth in incidence and second in
mortality among all cancers worldwide. Despite the decrease
in incidence in some regions of the world, gastric cancer
continues to present a major clinical challenge ...
Helicobacter pylori and gastric cancer: adaptive cellular mechanisms involved in disease progression
(Frontiers Media SA, 2018)
Helicobacter pylori (H. pylori) infection is the major risk factor associated with the development of gastric cancer. The transition from normal mucosa to non-atrophic gastritis, triggered primarily by H. pylori infection, ...
The reprimo-like gene is an epigenetic-mediated tumor suppressor and a candidate biomarker for the non-invasive detection of gastric cancer
(MDPI, 2020)
Reprimo-like (RPRML) is an uncharacterized member of the Reprimo gene family. Here, we evaluated the role of RPRML and whether its regulation by DNA methylation is a potential non-invasive biomarker of gastric cancer. RPRML ...
Gastric cancer: Nanoparticles as tools to improve treatment efficacy
(Bentham Science, 2016)
In recent years, advances in nanotechnology have raised the specter of developing effective agents for the treatment of high-impact diseases, like gastric cancer, which remains one of the major causes of cancer deaths ...
Increased expression of p2ry2, cd248 and ephb1 in gastric cancers from chilean patients
(National Cancer Center, 2014)
Background: Gastric cancer (GC) ranks as one of the major causes of mortality due to cancer worldwide. In Chile, it is currently the leading cause of cancer death. Identification of novel molecular markers that may help ...
Gastric cancer in Chile: A cooperative interhospital study III. Five-year survival rate
(1975)
This report showed the survival figures for gastric cancer in Chile. For the whole group, a survival rate of 6.6% was obtained. This figure can be divided into 19% for the resected cases and 0% for the non-resected patients.In ...
Minimally invasive surgery for gastric cancer Cirugía mínimamente invasiva del cáncer gástrico
(Sociedad de Cirujanos de Chile, 2020)